CHARTWELL INVESTMENT PARTNERS, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 219 filers reported holding BLUEBIRD BIO INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2018$1,438,000
-11.5%
9,161
-3.7%
0.04%
-23.2%
Q1 2018$1,624,000
-5.9%
9,509
-1.8%
0.06%
-5.1%
Q4 2017$1,725,000
-6.7%
9,686
-28.1%
0.06%
-6.3%
Q3 2017$1,849,000
+81.5%
13,468
+38.9%
0.06%
+65.8%
Q2 2017$1,019,000
+15.7%
9,699
+0.0%
0.04%
+18.8%
Q1 2017$881,000
-6.3%
9,695
-36.4%
0.03%0.0%
Q4 2016$940,000
-66.8%
15,240
-63.5%
0.03%
-36.0%
Q3 2016$2,830,00041,7550.05%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 1,834,965$35,066,0001.72%
Birchview Capital, LP 84,000$1,605,0001.09%
ARMISTICE CAPITAL, LLC 2,472,000$47,240,0000.80%
EcoR1 Capital, LLC 802,507$15,336,0000.53%
Parametrica Management Ltd 36,919$706,0000.53%
Bain Capital Life Sciences Investors, LLC 538,179$7,239,0000.45%
APPLETON GROUP, LLC 19,495$373,0000.32%
MANGROVE PARTNERS IM, LLC 175,587$3,355,0000.30%
Quinn Opportunity Partners LLC 230,100$4,397,0000.28%
PDT Partners, LLC 171,700$3,281,0000.24%
View complete list of BLUEBIRD BIO INC shareholders